The following impurities are available with SUMA Laboratories Pvt Limited. Click here to Download our impurities in pdf format...
Product list 351 - 400:
| S.No | Compound Name | CAS | Remarks |
|---|---|---|---|
| 351 | (2R,3S,4S,5R,6S)-2-(4-Chloro-3-(4-ethoxybenzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol | NA | Dapagliflozin Enantiomer |
| 352 | (4S,12aR)-N-(2,4-Difluorobenzyl)-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1`,2`:4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide | 1309560-49-3 | Dolutegravir Enantiomer (Dolutegravir SR Isomer) |
| 353 | (4R,12aR)-N-[(2,4-Difluorophenyl)methyl]-3,4,6,8,12,12a-hexahydro-7-hydroxy-4-methyl-6,8-dioxo-2H-pPyrido[1’,2’:4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide | 1357289-29-2 | Dolutegravir Diastereomer (Dolutegravir RR Isomer) |
| 354 | (4R,12aS)-N-Benzyl-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide | 2244161-71-3 | Desflouro Dolutegravir |
| 355 | (4R,12aS)-N-(4-Fluorobenzyl)-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1’,2’:4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide | 1863916-88-4 | 4-Flouro Dolutegravir |
| 356 | (4R,12aS)-N-(2-Fluorobenzyl)-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1’,2’:4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide | 1863916-87-3 | 2-Flouro Dolutegravir (Dolutegravir Impurity C) |
| 357 | (4R,12aS)-N-(2,6-Difluorobenzyl)-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide | 2244161-72-4 | 2, 6-Diflouro Dolutegravir |
| 358 | 2,4,6 -Trifluoro Dolutegravir | NA | 2,4,6 -Trifluoro Dolutegravir |
| 359 | 3,4 -Difluoro Dolutegravir | NA | 3,4 -Difluoro Dolutegravir |
| 360 | (4S,12aS)-N-[(2,4-Difluorophenyl)methyl]-3,4,6,8,12,12a-hexahydro-7-hydroxy-4-methyl-6,8-dioxo-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide | 1357289-37-2 | (4S,12aS) Dolutegravir (4-epi-Dolutegravir) |
| 361 | 5-Chlorobenzo[c][1,2,5]thiadiazol-4-amine | 30536-19-7 | Tizanidine EP impurity E |
| 362 | N-(5-Chlorobenzo[c][1,2,5]thiadiazol-4-yl)cyanamide | 51322-80-6 | Tizanidine EP impurity G |
| 363 | Isopropyl (Z)-7-((1S,2S,3S,5R)-3,5-Dihydroxy-2-((S)-3-hydroxy-5-phenylpentyl)cyclopentyl)hept-5-enoate | 130209-82-4 | Latanoprost Enantiomer |
| 364 | Isopropyl-(Z)-6-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]-4-hexenoat | NA | 2-Nor Latanoprost |
| 365 | (3S,4S)-1-(4-Fluorophenyl)-3-((S)-3-(4-fluorophenyl)-3-hydroxypropyl)-4-(4-hydroxyphenyl)azetidin-2-one | 1593543-07-7 | Ezetimibe (SSS)-Isomer |
| 366 | (3R,4R)-1-(4-Fluorophenyl)-3-((R)-3-(4-fluorophenyl)-3-hydroxypropyl)-4-(4-hydroxyphenyl)azetidin-2-one | 1593542-96-1 | Ezetimibe (RRR)-Isomer |
| 367 | (3R,4S)-1-(4-fluorophenyl)-3-((R)-3-(4-fluorophenyl)-3-hydroxypropyl)-4-(4-hydroxyphenyl)azetidin-2-one | 163380-16-3 | Ezetimibe (RRS)-Isomer |
| 368 | (3S,4R)-1-(4-Fluorophenyl)-3-((R)-3-(4-fluorophenyl)-3-hydroxypropyl)-4-(4-hydroxyphenyl)azetidin-2-one | 1376614-99-1 | Ezetimibe (RSR)-Isomer |
| 369 | (3S,4R)-1-(4-Fluorophenyl)-3-((S)-3-(4-fluorophenyl)-3-hydroxypropyl)-4-(4-hydroxyphenyl)azetidin-2-one | 1593543-00-0 | Ezetimibe (SSR)-Isomer |
| 370 | (3R,4S)-1-(4-Fluorophenyl)-3-(3-(4-fluorophenyl)-3-oxopropyl)-4-(4-hydroxyphenyl)azetidin-2-one | 191330-56-0 | Ezetimibe Ketone IMPURITY |
| 371 | (3R,4S)-1-(4-Fluorophenyl)-3-((S)-3-(2-fluorophenyl)-3-hydroxypropyl)-4-(4-hydroxyphenyl)azetidin-2-one | 1798008-25-9 | Ezetimibe o-Fluorobenzene Isomer |
| 372 | (3S, 4R)-1-(4-Fluorophenyl)-3-((S)-3-(4-fluorophenyl)-3-hydroxypropyl)-4-(4-hydroxyphenyl)azetidin-2-one | 1593543-00-0 | Ezetimibe SRS Impurity |
| 373 | (3R,4S)-1-(3-Fluorophenyl)-3-((S)-3-(4-fluorophenyl)-3-hydroxypropyl)-4-(4-hydroxyphenyl)azetidin-2-one | 1700622-06-5 | Ezetimibe m-fluoro aniline analog |
| 374 | (4aR,4bS,6aS,7S,9aS,9bS,11aR)-4a,6a-Dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxylic acid | 104239-97-6 | Dutasteride EP Impurity A |
| 375 | N,N-Dimethyl-3-oxo-4-aza-5α-androst-1-ene-17β-carboxamide | 2512195-98-9 | Dutasteride Dimethyl amide (EP Impurity B) |
| 376 | 3-Oxo-4-aza-5α-αndrost-1-ene-17β-carboxylic acid methyl ester | 103335-41-7 | Dutasteride Methyl ester (Finasteride EP Impurity B) |
| 377 | (6aS,7S,9aR)-N-(2,5-Bis(Trifluoromethyl)phenyl)-6a-methyl-2-oxo-2,5,6,6a,7,8,9,9a-octahydro-1H-indeno[5,4-f]quinoline-7-carboxamide | 952718-75-1 | Desmethyl Dutasteride |
| 378 | Ethyl 3-oxo-4-aza-5α-androst-1-ene-17β-carboxylate | 157307-36-3 | Dutasteride Ethyl Ester; Dutasteride EP Impurity C |
| 379 | (5α,17β)-N-[2,5-Bis (trifluoromethyl)phenyl]-3-oxo-4-azaandrostane-17-carboxamide | 164656-22-8 | Dutasteride dihydro Impurity |
| 380 | 1-(((Cyclohexyloxy)carbonyl)oxy)ethyl 2-ethoxy-1-((2'-(1-ethyl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate | 914613-35-7 | Candesartan Cilexetil EP Impurity E |
| 381 | 1-(((Cyclohexyloxy)carbonyl)oxy)ethyl 2-ethoxy-1-((2'-(2-ethyl-2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate | 914613-36-8 | Candesartan Cilexetil EP Impurity F |
| 382 | 1-(((Cyclohexyloxy)carbonyl)oxy)ethyl 1-((2'-(1-ethyl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-hydroxy-1H-benzo[d]imidazole-7-carboxylate | 1185255-99-5 | Candesartan Cilexetil EP Impurity C |
| 383 | 1-(((Cyclohexyloxy)carbonyl)oxy)ethyl 1-((2'-(2-ethyl-2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-hydroxy-1H-benzo[d]imidazole-7-carboxylate | 1185256-03-4 | Candesartan Cilexetil EP Impurity D |
| 384 | Ethyl 3-(2-(((4-(((hexyloxy)carbonyl)carbamoyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate | 1408238-40-3 | Dabigatran Etexilate Related Compound A |
| 385 | 2-Azaspiro[4.5]decan-3-one | 64744-50-9 | Gabapentin Impurity A |
| 386 | 2-(3-Oxo-2-azaspiro[4.5]decan-2-yl)acetic acid | 923281-89-4 | Gabapentine Impurity 45 |
| 387 | 1-(Isobutyryloxy)ethyl 3-oxo-2-azaspiro[4.5]decane-2-carboxylate | NA | Gabapentin Enacarbil Cyclic Impurity |
| 388 | 2,2'-(Ethane-1,1-diyl)bis(2-azaspiro[4.5]decan-3-one) | NA | Gabapentin Dilactam Impurity |
| 389 | Allyl 2-(1-(isobutyramidomethyl)cyclohexyl)acetate | NA | Gabapentin Allyl Impurity |
| 390 | Allyl 2-(1-(formamidomethyl)cyclohexyl)acetate | NA | Gabapentin Formyl Impurity |
| 391 | 1-(2-Aminoethyl)-3-(5-bromoquinoxalin-6-yl)urea hydrochloride | 1216379-05-3 | Brimonidine EP imp G HCl salt |
| 392 | 1-(2-Aminoethyl)-3-(5-bromoquinoxalin-6-yl)-1-((5-bromoquinoxalin-6-yl)carbamoyl)urea | NA | Brimonidine impurity |
| 393 | N-((1S,4S)-4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydronaphthalen-1-yl)-N-methylnitrous amide | NA | Sertraline Nitroso Impurity |
| 394 | Ethyl 2-benzyl-3-hydroxypropanoate | 87884-40-0 | (RS)-TROPIC ACID ETHYL ESTER |
| 395 | 1-[2-[(5-Chloro-2,1,3-benzothiadiazol-4-yl)amino]-4,5-dihydro-1H-imidazol-1-yl]-ethanone (or) 1-Acetyl-N-(5-chloro-2,1,3-benzothiadiazol-4-yl)-4,5-dihydro-1H-imidazol-2-amine | 173532-15-5 | Tizanidine USP Related Compound B |
| 396 | 1-Acetylimidazolidine-2-thione | 5391-52-6 | Tizanidine USP Related Compound C |
| 397 | 1-(5-bromoquinoxalin-6-yl)thiourea | 842138-74-3 | Brimonidine EP Impurity D |
| 398 | 2-(5-bromoquinoxalin-6-yl)guanidine | 168329-48-4 | Brimonidine EP Impurity E |
| 399 | N1,N4-dicyanopiperazine-1,4-bis(carboximidamide) | 19803-86-2 | N1,N4-dicyanopiperazine-1,4-bis(carboximidamide) |
| 400 | isopropyl (Z)-3-(2-(((4-(N'-((hexyloxy)carbonyl)carbamimidoyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate | 1610758-19-4 | O-Desethyl O-Isopropyl Dabigatran Etexilate |
| 401 | 4-(nitrooxy)butyl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((R)-3-hydroxy-5-phenylpentyl)cyclopentyl)hept-5-enoate | 860005-21-6 | Latanoprostene Bunod |
| 402 | 4-(nitrooxy)butyl 5-(triphenyl-l4-phosphaneyl)pentanoate | NA | 4-(nitrooxy)butyl 5-(triphenyl-l4-phosphaneyl)pentanoate(Wittig bunod) |
| 403 | (3-bromo-1H-indol-7-yl)(4-bromophenyl)methanone | 1279501-08-4 | Bromfenac Impurity A |
Suma Laboratories ® All rights reserved.